Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Potent new antibiotic isolated from soil microorganism undergoes further evaluation

Oct. 23, 1998

Monosaccharide conjugates of pyrimethamine and other therapeutic agents patented

Oct. 23, 1998

Lilly studies antiinfluenza virus drug candidate with a unique mechanism of action

Oct. 22, 1998

Ramoplanin enters phase II trials in U.S. for eliminating VREF from intestine

Oct. 22, 1998

Cephems from Zenyaku Kogyo with improved activity compared to flomoxef, vancomycin

Oct. 21, 1998

BMS acquires new antibacterial compound from Toyama

Oct. 20, 1998

2-5A-antisense chimer provides potent inhibition of RSV replication

Oct. 19, 1998

Genome Therapeutics first to sequence strains of Enterobacter and Acinetobacter

Oct. 19, 1998

Lead compound generated in Structural Bioinformatics/BioChem Pharma collaboration

Oct. 19, 1998

CollaGenex enters copromotion agreement with SmithKline Beecham

Oct. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...